glp-1 drugs available in usa The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Prescription Drug Spending Surges in
Description
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, et al
Upload your prescription
Ideal candidates for GLP-1 therapy, including Semaglutide and Tirzepatide treatments in NYC, are adults with a BMI of 27 or higher, particularly those with weight-related health issues
Body weight loss was more pronounced with tirzepatide than with semaglutide (LSM estimated treatment difference, 1.9, 3.6, and 5.5 kg, respectively
Lomaira is for adults with an initial BMI* of 30 or more (obese) or 27 or more (overweight) with at least one weight-related medical condition such as controlled high blood pressure, diabetes, or high cholesterol
therefore, ethical approval and informed consent were not required
